Co-Diagnostics, Inc. Quarterly Accounts Receivable, after Allowance for Credit Loss, Current in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount, after allowance for credit loss, of right to consideration from customer for product sold and service rendered in normal course of business, classified as current.
Summary
Co-Diagnostics, Inc. quarterly Accounts Receivable, after Allowance for Credit Loss, Current history and growth rate from Q4 2018 to Q2 2024.
  • Co-Diagnostics, Inc. Accounts Receivable, after Allowance for Credit Loss, Current for the quarter ending June 30, 2024 was $552K, a 49.7% decline year-over-year.
Accounts Receivable, after Allowance for Credit Loss, Current, Quarterly (USD)
Accounts Receivable, after Allowance for Credit Loss, Current, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $552K -$546K -49.7% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $435K -$2.27M -83.9% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $304K -$3.15M -91.2% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $807K -$7.15M -89.9% Sep 30, 2023 10-Q 2023-11-09
Q2 2023 $1.1M -$11.2M -91% Jun 30, 2023 10-Q 2023-08-10
Q1 2023 $2.7M -$19M -87.5% Mar 31, 2023 10-Q 2023-05-11
Q4 2022 $3.45M -$17.4M -83.4% Dec 31, 2022 10-K 2024-03-14
Q3 2022 $7.96M -$6.63M -45.4% Sep 30, 2022 10-Q 2022-11-10
Q2 2022 $12.3M -$496K -3.89% Jun 30, 2022 10-Q 2022-08-11
Q1 2022 $21.7M +$9.55M +78.8% Mar 31, 2022 10-Q 2022-05-12
Q4 2021 $20.8M +$8.7M +71.7% Dec 31, 2021 10-K 2023-03-16
Q3 2021 $14.6M +$3.95M +37.1% Sep 30, 2021 10-Q 2021-11-12
Q2 2021 $12.8M +$7.41M +138% Jun 30, 2021 10-Q 2021-08-12
Q1 2021 $12.1M +$11.1M +1048% Mar 31, 2021 10-Q 2021-05-13
Q4 2020 $12.1M +$12M +9138% Dec 31, 2020 10-K 2022-03-24
Q3 2020 $10.6M +$10.6M +17530% Sep 30, 2020 10-Q 2020-11-16
Q2 2020 $5.35M +$5.29M +8394% Jun 30, 2020 10-Q/A 2020-11-03
Q1 2020 $1.06M +$1.01M +2381% Mar 31, 2020 10-Q 2020-05-14
Q4 2019 $131K +$118K +879% Dec 31, 2019 10-K 2021-03-25
Q3 2019 $60.4K Sep 30, 2019 10-Q 2019-11-12
Q2 2019 $63K Jun 30, 2019 10-Q 2019-08-14
Q1 2019 $42.6K Mar 31, 2019 10-Q 2019-05-14
Q4 2018 $13.4K Dec 31, 2018 10-K 2020-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.